Report Overview
Report Summary
Eternity Insights has published a new study on Global Mydriatic Eyedrops Market focusing on key segments as by Type (Atropine, Homatropine, Dolly, Others), by Application (Adult, Children, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Mydriatic Eyedrops Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Mydriatic Eyedrops Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Mydriatic Eyedrops Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Mydriatic Eyedrops Market Segmentation:
Mydriatic Eyedrops Market, By Type
- Atropine
- Homatropine
- Dolly
- Others
Mydriatic Eyedrops Market, By Application
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Mydriatic Eyedrops market in terms of demand generation. The Mydriatic Eyedrops market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Mydriatic Eyedrops market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Mydriatic Eyedrops Market Taxonomy:
To learn more about this report
Global Mydriatic Eyedrops Market Competitive Landscape
The global Mydriatic Eyedrops market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Novartis AG
- Allergan
- Inc.
- Meda Pharmaceuticals Inc
- Bausch & Lomb Inc
- Cigna
- Similasan Corporation
- Visine
- Alcon
- Viva Opti-Free
- Bausch & Lomb
- Systane
- Rite Aid
- Walgreens
- Staples
- Clear eyes
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Atropine, Homatropine, Dolly, Others |
| By Application Outlook |
Adult, Children, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon, Viva Opti-Free, Bausch & Lomb, Systane, Rite Aid, Walgreens, Staples, Clear eyes |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table Of Contents
Table of Contents
1 Mydriatic Eyedrops Market Overview
1.1 Mydriatic Eyedrops Product Overview
1.2 Mydriatic Eyedrops Market Segment by Type
1.2.1 Atropine
1.2.2 Homatropine
1.2.3 Dolly
1.2.4 Others
1.3 Global Mydriatic Eyedrops Market Size by Type
1.3.1 Global Mydriatic Eyedrops Sales and Growth by Type
1.3.2 Global Mydriatic Eyedrops Sales and Market Share by Type (2013-2018)
1.3.3 Global Mydriatic Eyedrops Revenue and Market Share by Type (2013-2018)
1.3.4 Global Mydriatic Eyedrops Price by Type (2013-2018)
2 Global Mydriatic Eyedrops Market Competition by Company
2.1 Global Mydriatic Eyedrops Sales and Market Share by Company (2013-2018)
2.2 Global Mydriatic Eyedrops Revenue and Share by Company (2013-2018)
2.3 Global Mydriatic Eyedrops Price by Company (2013-2018)
2.4 Global Top Players Mydriatic Eyedrops Manufacturing Base Distribution, Sales Area, Product Types
2.5 Mydriatic Eyedrops Market Competitive Situation and Trends
2.5.1 Mydriatic Eyedrops Market Concentration Rate
2.5.2 Global Mydriatic Eyedrops Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Mydriatic Eyedrops Company Profiles and Sales Data
3.1 Novartis AG
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Mydriatic Eyedrops Product Category, Application and Specification
3.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Allergan, Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Mydriatic Eyedrops Product Category, Application and Specification
3.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Meda Pharmaceuticals Inc
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Mydriatic Eyedrops Product Category, Application and Specification
3.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Bausch & Lomb Inc
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Mydriatic Eyedrops Product Category, Application and Specification
3.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Cigna
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Mydriatic Eyedrops Product Category, Application and Specification
3.5.3 Cigna Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Similasan Corporation
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Mydriatic Eyedrops Product Category, Application and Specification
3.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Visine
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Mydriatic Eyedrops Product Category, Application and Specification
3.7.3 Visine Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Alcon
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Mydriatic Eyedrops Product Category, Application and Specification
3.8.3 Alcon Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Viva Opti-Free
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Mydriatic Eyedrops Product Category, Application and Specification
3.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 Bausch & Lomb
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Mydriatic Eyedrops Product Category, Application and Specification
3.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
3.11 Systane
3.12 Rite Aid
3.13 Walgreens
3.14 Staples
3.15 Clear eyes
4 Mydriatic Eyedrops Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Mydriatic Eyedrops Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Mydriatic Eyedrops Sales and Revenue by Regions
4.2.1 Global Mydriatic Eyedrops Sales and Market Share by Regions (2013-2018)
4.2.2 Global Mydriatic Eyedrops Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Mydriatic Eyedrops Application/End Users
5.1 Mydriatic Eyedrops Segment by Application
5.1.1 Adult
5.1.2 Children
5.2 Global Mydriatic Eyedrops Product Segment by Application
5.2.1 Global Mydriatic Eyedrops Sales by Application
5.2.2 Global Mydriatic Eyedrops Sales and Market Share by Application (2013-2018)
6 Global Mydriatic Eyedrops Market Forecast
6.1 Global Mydriatic Eyedrops Sales, Revenue Forecast (2018-2025)
6.1.1 Global Mydriatic Eyedrops Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Mydriatic Eyedrops Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Mydriatic Eyedrops Forecast by Regions
6.2.1 North America Mydriatic Eyedrops Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Mydriatic Eyedrops Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Mydriatic Eyedrops Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Mydriatic Eyedrops Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Mydriatic Eyedrops Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Mydriatic Eyedrops Forecast by Type
6.3.1 Global Mydriatic Eyedrops Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Atropine Gowth Forecast
6.3.3 Homatropine Gowth Forecast
6.4 Mydriatic Eyedrops Forecast by Application
6.4.1 Global Mydriatic Eyedrops Sales Forecast by Application (2018-2025)
6.4.2 Global Mydriatic Eyedrops Forecast in Adult
6.4.3 Global Mydriatic Eyedrops Forecast in Children
7 Mydriatic Eyedrops Upstream Raw Materials
7.1 Mydriatic Eyedrops Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Mydriatic Eyedrops Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer